ClinicalTrialsFinder

Recurrent Nasal Cavity Squamous Cell Carcinoma Clinical Trials in New Orleans, Louisiana

1 recruitingNew Orleans, Louisiana

Showing 1–1 of 1 trials

Recruiting
Phase 2

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaStage III Laryngeal Cancer AJCC v8+19 more
National Cancer Institute (NCI)44 enrolled5 locationsNCT06980038